Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05110911
What this trial is testing

Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection

Who this might be right for
Influenza, HumanSARS-CoV-2 Infection
University of Melbourne 1,500
Not applicableStudy completedNCT04646239
What this trial is testing

Biomarkers of Trained Immunity Following MMR Vaccination

Who this might be right for
Covid19
Washington University School of Medicine 96
Not applicableActive Not RecruitingNCT04924803
What this trial is testing

Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs

Who this might be right for
Covid19
NDRI-USA, Inc. 545
Post-approval studies (Phase 4)UnknownNCT05104437
What this trial is testing

Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes

Who this might be right for
COVID-19 Pneumonia
China National Biotec Group Company Limited 1,440
Not applicableStudy completedNCT06690502
What this trial is testing

Post Authorization Safety Profile of Booster IndoVac COVID-19 Vaccination

Who this might be right for
COVID-19
PT Bio Farma 1,208
Post-approval studies (Phase 4)Study completedNCT04369794
What this trial is testing

COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement

Who this might be right for
COVID-19Therapeutic VaccineBCG+2 more
University of Campinas, Brazil 400
Testing effectiveness (Phase 2)Study completedNCT05696067
What this trial is testing

Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers

Who this might be right for
COVID-19
Tatyana Zubkova 200
Not applicableStudy completedNCT04779138
What this trial is testing

Increasing Vaccine Uptake in Underresourced Public Housing Areas

Who this might be right for
CoronavirusVaccine Refusal
Charles Drew University of Medicine and Science 462
Large-scale testing (Phase 3)Study completedNCT05398848
What this trial is testing

Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov)

Who this might be right for
COVID-19
Jiangsu Rec-Biotechnology Co., Ltd. 7,623
Not applicableUnknownNCT05483725
What this trial is testing

Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.

Who this might be right for
Kidney DiseasesKidney Transplant; ComplicationsCOVID-19+3 more
Institute for Clinical and Experimental Medicine 108
Large-scale testing (Phase 3)Looking for participantsNCT07655180
What this trial is testing

Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

Who this might be right for
COVID-19
Invivyd, Inc. 210
Not applicableUnknownNCT05630313
What this trial is testing

Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil

Who this might be right for
Vaccine-induced Thrombotic Thrombocytopenia SyndromeGuillain-Barre SyndromeAcute Disseminated Encephalomyelitis+1 more
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 100
Not applicableUnknownNCT05193903
What this trial is testing

Evaluation of an Interactive Risk Information Tool to Increase COVID-19 Vaccination Incidence in Vaccine-hesitant People

Who this might be right for
COVID-19 Infection
Charite University, Berlin, Germany 1,188
Early research (Phase 1)UnknownNCT05171946
What this trial is testing

Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults

Who this might be right for
SafetyVaccine ReactionVaccine Adverse Reaction+1 more
Iman Almansour 30
Testing effectiveness (Phase 2)Study completedNCT07134725
What this trial is testing

Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG

Who this might be right for
COVID - 19
Federal University of Minas Gerais 432
Not applicableEnrolling By InvitationNCT05610423
What this trial is testing

Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway

Who this might be right for
Myocarditis
Oslo University Hospital 100
Not applicableUnknownNCT05362682
What this trial is testing

Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique

Who this might be right for
Sars-CoV-2 Infection
International Vaccine Institute 3,000
Testing effectiveness (Phase 2)Study completedNCT05639998
What this trial is testing

BBV152/BBV154 Heterologus Prime-Boost Study

Who this might be right for
Corona Virus Infection
Bharat Biotech International Limited 608
Not applicableWithdrawnNCT06505993
What this trial is testing

Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia

Who this might be right for
COVID-19Vaccine Hesitancy
Marc Kiviniemi
Not applicableLooking for participantsNCT06848309
What this trial is testing

Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2

Who this might be right for
InfluenzaSARS-CoV-2 (COVID-19) InfectionImmune Response of Host
Washington University School of Medicine 300
Next Page